Trends in net survival from pancreatic cancer in six European Latin countries

Anne-Marie Bouvier, Nadine Bossard, Marc Colonna, Adelaida Garcia-Velasco, Maria Carulla, Sylvain Manfredi, GRELL EUROCARE-5 Working Group, Gemma Gatta, Milena Sant, Hade Amash, Lucia Mangone

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Pancreatic cancer represents a real clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from pancreatic cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. Results were reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in age-standardized net survivals (2000-2004). The 5-year net survival was poor (range: 6-10%). The changes in net survival from 1992 to 2004 were mostly related to early survival and patients aged 60 years. A slight decrease in the excess mortality rate between 1992 and 2004 was observed, limited to the 18 months after diagnosis. This study confirmed that, despite some improvement, survival from pancreatic cancer is still poor throughout European Latin countries. The major improvements in clinical imaging did not result in improvements in prognosis. Development of truly innovative treatments is highly needed to improve prognosis.
Original languageEnglish
Pages (from-to)S63-S69
JournalEuropean Journal of Cancer Prevention
Volume26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study
DOIs
Publication statusPublished - Jan 2017

Fingerprint

Pancreatic Neoplasms
Survival
Portugal
Mortality
Belgium
Switzerland
Spain
Italy
France
Demography
Databases

Keywords

  • Journal Article

Cite this

Bouvier, A-M., Bossard, N., Colonna, M., Garcia-Velasco, A., Carulla, M., Manfredi, S., ... Mangone, L. (2017). Trends in net survival from pancreatic cancer in six European Latin countries. European Journal of Cancer Prevention, 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study, S63-S69. https://doi.org/10.1097/CEJ.0000000000000303

Trends in net survival from pancreatic cancer in six European Latin countries. / Bouvier, Anne-Marie; Bossard, Nadine; Colonna, Marc; Garcia-Velasco, Adelaida; Carulla, Maria; Manfredi, Sylvain; Group, GRELL EUROCARE-5 Working; Gatta, Gemma; Sant, Milena; Amash, Hade; Mangone, Lucia.

In: European Journal of Cancer Prevention, Vol. 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study, 01.2017, p. S63-S69.

Research output: Contribution to journalArticle

Bouvier, A-M, Bossard, N, Colonna, M, Garcia-Velasco, A, Carulla, M, Manfredi, S, Group, GRELLEUROCAREW, Gatta, G, Sant, M, Amash, H & Mangone, L 2017, 'Trends in net survival from pancreatic cancer in six European Latin countries', European Journal of Cancer Prevention, vol. 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S63-S69. https://doi.org/10.1097/CEJ.0000000000000303
Bouvier A-M, Bossard N, Colonna M, Garcia-Velasco A, Carulla M, Manfredi S et al. Trends in net survival from pancreatic cancer in six European Latin countries. European Journal of Cancer Prevention. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S63-S69. https://doi.org/10.1097/CEJ.0000000000000303
Bouvier, Anne-Marie ; Bossard, Nadine ; Colonna, Marc ; Garcia-Velasco, Adelaida ; Carulla, Maria ; Manfredi, Sylvain ; Group, GRELL EUROCARE-5 Working ; Gatta, Gemma ; Sant, Milena ; Amash, Hade ; Mangone, Lucia. / Trends in net survival from pancreatic cancer in six European Latin countries. In: European Journal of Cancer Prevention. 2017 ; Vol. 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study. pp. S63-S69.
@article{dacb87ee759d4dac94bff55140145ae3,
title = "Trends in net survival from pancreatic cancer in six European Latin countries",
abstract = "Pancreatic cancer represents a real clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from pancreatic cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. Results were reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in age-standardized net survivals (2000-2004). The 5-year net survival was poor (range: 6-10{\%}). The changes in net survival from 1992 to 2004 were mostly related to early survival and patients aged 60 years. A slight decrease in the excess mortality rate between 1992 and 2004 was observed, limited to the 18 months after diagnosis. This study confirmed that, despite some improvement, survival from pancreatic cancer is still poor throughout European Latin countries. The major improvements in clinical imaging did not result in improvements in prognosis. Development of truly innovative treatments is highly needed to improve prognosis.",
keywords = "Journal Article",
author = "Anne-Marie Bouvier and Nadine Bossard and Marc Colonna and Adelaida Garcia-Velasco and Maria Carulla and Sylvain Manfredi and Group, {GRELL EUROCARE-5 Working} and Gemma Gatta and Milena Sant and Hade Amash and Lucia Mangone",
year = "2017",
month = "1",
doi = "10.1097/CEJ.0000000000000303",
language = "English",
volume = "26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study",
pages = "S63--S69",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Trends in net survival from pancreatic cancer in six European Latin countries

AU - Bouvier, Anne-Marie

AU - Bossard, Nadine

AU - Colonna, Marc

AU - Garcia-Velasco, Adelaida

AU - Carulla, Maria

AU - Manfredi, Sylvain

AU - Group, GRELL EUROCARE-5 Working

AU - Gatta, Gemma

AU - Sant, Milena

AU - Amash, Hade

AU - Mangone, Lucia

PY - 2017/1

Y1 - 2017/1

N2 - Pancreatic cancer represents a real clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from pancreatic cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. Results were reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in age-standardized net survivals (2000-2004). The 5-year net survival was poor (range: 6-10%). The changes in net survival from 1992 to 2004 were mostly related to early survival and patients aged 60 years. A slight decrease in the excess mortality rate between 1992 and 2004 was observed, limited to the 18 months after diagnosis. This study confirmed that, despite some improvement, survival from pancreatic cancer is still poor throughout European Latin countries. The major improvements in clinical imaging did not result in improvements in prognosis. Development of truly innovative treatments is highly needed to improve prognosis.

AB - Pancreatic cancer represents a real clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from pancreatic cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. Results were reported from 1992 to 2004 in France, Italy, Spain and Switzerland and from 2000 to 2004 in Belgium and Portugal. These analyses were carried out using a flexible excess rate modelling strategy. There were little differences between countries in age-standardized net survivals (2000-2004). The 5-year net survival was poor (range: 6-10%). The changes in net survival from 1992 to 2004 were mostly related to early survival and patients aged 60 years. A slight decrease in the excess mortality rate between 1992 and 2004 was observed, limited to the 18 months after diagnosis. This study confirmed that, despite some improvement, survival from pancreatic cancer is still poor throughout European Latin countries. The major improvements in clinical imaging did not result in improvements in prognosis. Development of truly innovative treatments is highly needed to improve prognosis.

KW - Journal Article

U2 - 10.1097/CEJ.0000000000000303

DO - 10.1097/CEJ.0000000000000303

M3 - Article

VL - 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study

SP - S63-S69

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

ER -